Practice Areas

Patents, Biotechnology/ Pharmaceutical, Chemical

Qualifications

McGill University B.Sc.Hons. (Biochemistry) 1998 (Dean's Honour List).
Dalhousie University M.Sc. (Biochemistry/Molecular Biology) 2000; thesis titled Identification of yeast proteins compensating for the loss of ARF GAP function.
Université Laval Ph.D. (Molecular/Cellular Biology) 2005 (Dean's Honour List); thesis titled Functional and structural studies of histone H4 acetyltransferase complexe NuA4 in relation with chromatin remodeling activities.
Registered Patent Agent 2008.
Registered to practise before the United States Patent and Trademark Office.

Biography

Andréanne Auger is an associate in our Montreal office. Her practice focuses on the preparation and prosecution of patent applications, primarily in the areas of biochemistry, biology, molecular and cellular biology, pharmacology and chemistry. Ms. Auger is also involved in patent portfolio management, freedom-to-operate (FTO) assessments, infringement and validity opinions and in providing technical support to our litigation team.

She provides services to a broad range of clients, including multinationals, small and medium size companies, universities, hospitals and research institutes.

She received numerous prestigious scholarships, including post-graduate scholarships from the Natural Sciences and Engineering Research Council of Canada and the Fonds de la Recherche en Santé du Québec.

Ms. Auger is fluent in English and French.

Professional Involvement

• Associate, Intellectual Property Institute of Canada
• Member, Ordre des chimistes du Québec
• Member, BIOQuebec 

Publications

Altaf, M., Auger, A., Covic, M. and Côté, J. "Connection between histone H2A variants and chromatin remodeling complexes." Biochem Cell Biol., February 2009; 87(1):35-50.

Auger, A., Galarneau, L., Altaf, M., Nourani, A., Doyon, Y., Utley, R. T., Cronier, D., Allard, S. and Côté, J.  "Eaf1 is the platform for NuA4 molecular assembly that evolutionarily links chromatin acetylation to ATP-dependent exchange of histone H2A variants."  Mol Cell Biol., April 2008; 28(7):2257-70.

Auger, A. and Elvira, G.  "Intellectual Property Rights: a Key Asset for Early Stage Biotechnology Companies." The Lawyers Weekly Magazine, February 2008.

Downs, J. A., Allard, S., Jobin-Robitaille, O., Javaheri, A., Auger, A., Bouchard, N., Kron, S. J., Jackson, S. P. and Côté, J.  "Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites." Mol Cell., December 22, 2004; 16(6):979-90.